Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Am J Transplant. 2016 Jun 27;16(9):2747–2752. doi: 10.1111/ajt.13851

Table 1.

Results of miRNA -10b, -30c, and -106b analysis of serum samples taken prior to surgery and on PODs 1 and 3

Serum CP only (n = 4)
CP and PDAC (n = 1)
Preoperative POD 1 POD 3 Preoperative POD 1 POD 3
miRNA 10b 0.33 ± 0.18 0.41 ± 0.18 0.18 ± 0.12 6.53 ± 1.18** 0.28 0.30
miRNA 30c 2.00 ± 0.82 2.91 ± 1.12 1.53 ± 0.68 9.65 ± 0.50** 3.82 2.72
miRNA 106b 0.25 ± 0.04 0.25 ± 0.18 0.22 ± 0.04 1.79 ± 0.11* 0.51 0.47

Data shown are relative expression levels by comparison to the mean values in 6 healthy controls. Please see changes to the Methods section for further clarification.

CP, chronic pancreatitis; miRNA, microRNA; PDAC, pancreatic ductal adenocarcinoma; POD, preoperative day.